Simultaneous administration of ENO1i and BTZ to MM cells led to more potent cytotoxic effects (Fig. 4A, left panel) and significantly higher levels of apoptosis (Fig. 4B) than that observed upon independent treatment with either ENO1i or BTZ. This evidence concerns the gene CASC3 and Miyoshi myopathy.